News

A public feud over model originality threatens China’s collaborative AI front, with Huawei denying whistleblower claims of ...
The decision to end the service was ultimately made by the US Department of Defense (DoD) and affects data collected by the ...
Google DeepMind's drug discovery company, Isomorphic Labs, is gearing up to launch the human trials of its AI-designed drugs.
Alphabet's AI drug development subsidiary Isomorphic Labs is aiming to initiate clinical trials for its AI-developed oncology drugs. In an interview with Fortune, Isomorphic Labs president Colin ...
Isomorphic Labs advances towards human clinical trials for AI-designed drugs, marking a pivotal moment in pharmaceutical ...
Computers can help ensure that mathematical proofs are correct, but translating traditional maths into a machine-readable ...
Google DeepMind's Isomorphic Labs is preparing for human trials of AI-designed drugs, marking a significant advancement in ...
One day we hope to be able to say — well, here’s a disease, and then click a button and out pops the design for a drug to ...
From Meta to Microsoft, generative AI is accelerating Big Tech's salary divide.
Credit: Google. Veo 3 it is finally also arrived in Italyand its availability represents a turning point in the field ...
OpenAI co-founder Ilya Sutskever has been named CEO of his artificial intelligence startup Safe Superintelligence. His ...
DeepMind's new AI system gives robots an inner voice, enabling zero-shot learning and efficient task mastery without prior ...